Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuetian Yan

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Pharmaceutical Sciences|June 22, 2017
Mapping the Binding Interface in a Noncovalent Size Variant of a Monoclonal Antibody Using Native Mass Spectrometry, Hydrogen-Deuterium Exchange Mass Spectrometry, and Computational AnalysisYuetian Yan, Hui Wei, Sutjano Jusuf, et al.
Analytical Chemistry|January 30, 2016
Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass SpectrometryYuetian Yan, Hui Wei, Ya Fu, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 1, 2024
Distinct chemical degradation pathways of AAV1 and AAV8 under thermal stress conditions revealed by analytical anion exchange chromatography and LC-MS-based peptide mappingTao Xing, Shuai Li, Shuli Tang, et al.
Biochemistry|May 3, 2014
Analysis of SecA dimerization in solutionAndy J Wowor, Yuetian Yan, Sarah M Auclair, et al.
The AAPS Journal|May 11, 2026
In-depth Characterization of Photo-Stressed Antibody-Drug Conjugates by Mass SpectrometryXiao Pan, Yimeng Zhao, Shukun Luo, et al.
Journal of Pharmaceutical Sciences|March 1, 2025
A target affinity enrichment workflow to characterize critical post-translational modifications within therapeutic antibodiesJethro E Prinston, Wenjing Peng, Kathleen Provoncha, et al.
Mabs|August 11, 2025
The nonglycosylated variant in therapeutic monoclonal antibodies preferentially forms large aggregates under typical thermal stresses used in forced degradation studiesGao-Yuan Liu, Jenny Kim Kim, Shuli Tang, et al.
Mabs|April 9, 2024
Enrichment strategy and initial characterization of heterodimers enriched from a co-formulated cocktail of therapeutic antibodies against SARS-COV-2Sophia Liu, Yuetian Yan, Cody M Secor, et al.
Scientific Reports|February 3, 2026
Insights into the structural differences between homo- and heterodimers enriched from a cocktail of monoclonal antibodies against SARS-CoV-2Jennifer B Nguyen, Sophia Liu, Yuetian Yan, et al.
Gene Therapy|February 12, 2026
Comprehensive forced degradation study revealing diverse chemical and physical degradation pathways of AAV8Kuan-Yu Lai, Song Nie, Yu-Chieh Ariel Chen, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Pharmaceutical Sciences|June 22, 2017
Mapping the Binding Interface in a Noncovalent Size Variant of a Monoclonal Antibody Using Native Mass Spectrometry, Hydrogen-Deuterium Exchange Mass Spectrometry, and Computational AnalysisYuetian Yan, Hui Wei, Sutjano Jusuf, et al.
Analytical Chemistry|January 30, 2016
Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass SpectrometryYuetian Yan, Hui Wei, Ya Fu, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 1, 2024
Distinct chemical degradation pathways of AAV1 and AAV8 under thermal stress conditions revealed by analytical anion exchange chromatography and LC-MS-based peptide mappingTao Xing, Shuai Li, Shuli Tang, et al.
Biochemistry|May 3, 2014
Analysis of SecA dimerization in solutionAndy J Wowor, Yuetian Yan, Sarah M Auclair, et al.
The AAPS Journal|May 11, 2026
In-depth Characterization of Photo-Stressed Antibody-Drug Conjugates by Mass SpectrometryXiao Pan, Yimeng Zhao, Shukun Luo, et al.
Journal of Pharmaceutical Sciences|March 1, 2025
A target affinity enrichment workflow to characterize critical post-translational modifications within therapeutic antibodiesJethro E Prinston, Wenjing Peng, Kathleen Provoncha, et al.
Mabs|August 11, 2025
The nonglycosylated variant in therapeutic monoclonal antibodies preferentially forms large aggregates under typical thermal stresses used in forced degradation studiesGao-Yuan Liu, Jenny Kim Kim, Shuli Tang, et al.
Mabs|April 9, 2024
Enrichment strategy and initial characterization of heterodimers enriched from a co-formulated cocktail of therapeutic antibodies against SARS-COV-2Sophia Liu, Yuetian Yan, Cody M Secor, et al.
Scientific Reports|February 3, 2026
Insights into the structural differences between homo- and heterodimers enriched from a cocktail of monoclonal antibodies against SARS-CoV-2Jennifer B Nguyen, Sophia Liu, Yuetian Yan, et al.
Gene Therapy|February 12, 2026
Comprehensive forced degradation study revealing diverse chemical and physical degradation pathways of AAV8Kuan-Yu Lai, Song Nie, Yu-Chieh Ariel Chen, et al.
Pageof 5